Prevention of acute NSAID-related gastroduodenal damage: A meta-analysis of controlled clinical trials

Digestive Diseases and Sciences

Volumn 46, Issue 9, 2001, Pages 1924-1936

  Leandro, G ^a   Pilotto, A ^a   Franceschi, M ^a   Bertin, T ^a   Lichino, E ^a   Di Mario, F ^a  

^a IRCCS   (Italy)

Author keywords

Damage prevention; Gastroduodenal damage; Meta analysis; NSAIDs

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTHRITIS; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; GASTRODUODENAL ULCER; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STOMACH PROTECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ARTHRITIS; CONTROLLED CLINICAL TRIALS; DUODENUM; HISTAMINE H2 ANTAGONISTS; HUMANS; MISOPROSTOL; PROTON PUMPS; STOMACH;

EID: 0034855861     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010687115298     Document Type: Article

References (46)

1. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs
2. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly
3. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs
4. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly
5. Role of Helicobacter priori infection on upper gastrointestinal bleeding in the elderly: A case-control study
6. Clinical presentation of bleeding peptic ulcer in the elderly
7. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double blind, placebo-controlled trial
8. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration
9. Primary gastroduonal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
10. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs
11. Omperazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs
12. NSAID-induced gastroduodenal damage: Is prevention needed? A review and metaanalysis
13. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials
14. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa
15. Meta analysis
16. A note on graphical presentation of estimated odds ratios from several clinical trials
17. Short-term treatment of gastric ulcer: Meta-analytic evaluation of blind trials
18. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis
19. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
20. The 'file-drawer problem' and tolerance for null results
21. Total parenteral nutrition nad cancer clinical trials
22. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study
23. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetine-induced mucosal injury to the stomach and duodenum
24. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration
25. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
26. Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study
27. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoartritis and rheumatoid artritis
28. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits
29. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine
30. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy
31. Cimetidine decreases indomethacin-induced duodenal mucosal damage in patients with acute musculoskeletal disorders
32. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
33. Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine
34. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs
35. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury. Effect of scoring method
36. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen
37. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
38. Protection against aspirin-induced gastric lesions by lansoprazole: Simultaneous evaluation of functional and morphologic responses
39. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study
40. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal anti-inflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial
41. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAID treatment
42. Omeprazole ameliorates aspirin-induced gastroduodenal injury
43. Upper gastrointestinal diseases in the elderly
44. The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs
45. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use
46. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drugs treatment in rheumatoid arthritis: Aprospective observational cohort study